$CVSI News
Last published 3mo ago
- 3mo agoCVSICV Sciences, Inc. Q2 2026 Earnings Call - CV Sciences, Inc.Earnings Call TranscriptsGreetings. Welcome to the CV Sciences Incorporated Q2 2026 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should requ
- 3y agoCVSICV Sciences, Inc. Launches Reserve Sleep GummiesPR NewswirePremium sleep aid supports better sleep by combining melatonin and cannabinoids SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",
- 3y agoCVSICV Sciences, Inc. Reports Second Quarter 2023 Financial ResultsPR NewswireSAN DIEGO, Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 3y agoCVSICV Sciences to Participate in LD Micro Invitational ConferencePR Newswire13th invitational event welcomes over 150 companies to over 800 attendees SAN DIEGO, June 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us"
- 3y agoCVSICV Sciences, Inc. Reports First Quarter 2023 Financial ResultsPR NewswireSAN DIEGO, May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 3y agoCVSICV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023PR NewswireSAN DIEGO, May 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 3y agoCVSICV Sciences, Inc. Reports Fiscal Year-End 2022 Financial ResultsPR NewswireSAN DIEGO, March 29, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 3y agoCVSICV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023PR NewswireSAN DIEGO, March 24, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 3y agoCVSICV Sciences, Inc. Announces Proposed Settlement of Shareholder LitigationPR NewswireSAN DIEGO, March 2, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 3y agoCVSICV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection SoftgelsPR NewswireSmaller bottle allows for consumers flexibility at a more affordable price SAN DIEGO, Jan. 19, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",
- 3y agoCVSICV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection SoftgelsPR NewswireSmaller bottle allows for consumers flexibility at a more affordable price SAN DIEGO, Jan. 18, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our",
- 3y agoCVSICV Sciences, Inc. Reports Third Quarter 2022 Financial ResultsPR NewswireSAN DIEGO, Nov. 14, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
- 4y agoCVSICV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022PR NewswireSAN DIEGO, Nov. 8, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp
- 4y agoCVSICV Sciences, Inc. Announces Proposed Settlement of Shareholder LitigationPR NewswireSAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and pr
- 4y agoCVSICV Sciences, Inc. Extinguishes Convertible DebtPR NewswireSAN DIEGO, Aug. 25, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and pro
- 4y agoCVSICV Sciences, Inc. Announces Launch of PlusCBD™ Reserve Collection SoftgelsPR NewswirePlusCBD™'s latest product leverages CBD and THC to target anxiety and stress SAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company speciali
- 4y agoCVSICV Sciences, Inc. Reports Second Quarter 2022 Financial ResultsPR NewswireSAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and pro
- 4y agoCVSICV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2022 RESULTS ON AUGUST 15, 2022PR NewswireSAN DIEGO, Aug. 9, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial results
- 4y agoCVSICV Sciences, Inc. Reports First Quarter 2022 Financial ResultsGlobeNewswireSAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the qua
- 4y agoCVSICV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022GlobeNewswireSAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial r
- 4y agoCVSICV Sciences, Inc. Reports Fiscal Year-End 2021 Financial ResultsGlobeNewswireSAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the y
- 4y agoCVSICV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022GlobeNewswireSAN DIEGO, March 28, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial
- 4y agoCVSICV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD ProductsGlobeNewswireSAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced the addition of +PlusCBD Relief
- 4y agoCCHWFCLCFFCVSIDLTNF+15Cannabis Industry Investor Presentations Now Available for On-Demand ViewingGlobeNewswireNEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the January 19th and 20th Cannabis Industry Virtual lnvestor Conference are now available
- 4y agoCCHWFCLCFFCVSIDLTNF+15Cannabis Industry Investor Conference: Company Executives Present January 19th & 20thGlobeNewswireNEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional in
- 4y agoCVSICV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief TopicalsGlobeNewswireSAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol ("CBD") products, today announced the launch of +PlusCBD™ Pai
- 4y agoCVSICV Sciences, Inc. Announces New Distribution Agreement with GNCGlobeNewswireSAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced a major new distribution agreeme
- 4y agoCVSICV Sciences, Inc. Appoints Haskell & White LLP as AuditorGlobeNewswireSAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it has appointed Haskell &
- 4y agoAGFYCVSICWBHFGRVI+1Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028PR Newswire- FinancialNewsMedia.com News Commentary - PALM BEACH, Fl., Nov. 15, 2021 /PRNewswire/ -- Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabi
- 4y agoCVSICV Sciences, Inc. Announces Convertible Note FinancingGlobeNewswireSAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it has entered into a secur
- 4y agoCVSICV Sciences, Inc. Reports Third Quarter 2021 Financial ResultsGlobeNewswireSAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the qu
- 5y agoCVSICV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021GlobeNewswireSAN DIEGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial r
- 5y agoCVSICV Sciences, Inc. Applauds the California Legislature for Passage of AB 45GlobeNewswireSAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, applauds the California Legislature of its passa
- 5y agoCVSICV Sciences, Inc. Reports Second Quarter 2021 Financial ResultsGlobeNewswireSAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the qu
- 5y agoCVSICV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021GlobeNewswireSAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial r
- 5y agoCVSICV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support AwardGlobeNewswireSAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, announced today that it received NutraIngredient
- 5y agoCVSICV Sciences, Inc. Reports First Quarter 2021 Financial ResultsGlobeNewswireSAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the qua
- 5y agoCVSICV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep GummiesGlobeNewswireSAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of PlusCBD™ Calm and Sleep: two
- 5y agoCVSICV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021GlobeNewswireSAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial re
- 6y agoSHAKCVSIAWSMMDXGSEC Troubles Are No Bar to Getting Small-Business Relief FundsBloombergA penny-stock company under investigation by the Securities and Exchange Commission for market manipulation in connection with a 300% jump in its shares two years ago got a $3.1 million loan from the government’s coronavirus relief fund for small businesses.